| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.32 | 6e-11 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-10 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |